| Literature DB >> 35431546 |
Ruiting Shen1, Keyu Zong2, Jie Liu1, Liancheng Zhang1.
Abstract
Purpose: Tuberculosis (TB) is a life threatening global infection. However, not only does TB have a high global prevalence, but it is also associated with several comorbidities. Depression is one of the most common and lethal comorbidities of TB patients. Therefore, in order to prevent depression in TB patients more effectively, it is necessary to investigate the factors associated with depression in TB patients by studying the pooled effect of each factor statistically. By concluding the associated factors through statistical analysis, it not only offers accurate guidance for further studies about programs targeted at preventing depression in TB patients, but provides health-care workers useful suggestions and warnings when treating TB patients.Entities:
Keywords: depression; meta-analysis; risk factors; tuberculosis
Year: 2022 PMID: 35431546 PMCID: PMC9012238 DOI: 10.2147/NDT.S347579
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.989
Figure 1Flowchart of study selection.
Basic Characteristics of the Included Studies
| Ambaw et al., 2017 | Ethiopia | cross-sectional | 346 (172/174) | 298 (174/124) | PHQ-9 | High quality (15) | |
| Naidu et al., 2020 | South Africa | cohort study | 21 (3/18) | 179 (36/143) | MINI-Plus | High quality (7) | |
| Mohammedhussein et al., 2020 | Ethiopia | cross-sectional | 229 (97/132) | 181 (114/67) | 31.85±12.42 | HADS | Low quality (13) |
| Dasa et al.,2019 | Ethiopia | cross-sectional | 209 | 194 | PHQ-9 | Low quality (13) | |
| Castro-Silva et al., 2018 | Brazil | cross-sectional | 99 (62/37) | 161 (98/63) | PHQ-9 | Low quality (13) | |
| Santos et al., 2017 | Brazil | cross-sectional | 27 (17/10) | 59 (43/16) | 44.6±15.4 | HADS | High quality (15) |
| Duko et al., 2015 | Ethiopia | cross-sectional | 181 | 236 | 34.52±11.01 | HADS | High quality (14) |
| Kehbila et al., 2016 | Cameroon | cross-sectional | 162 (60/102) | 103 (69/34) | 37±10.1 | PHQ-9 | High quality (14) |
| Molla et al., 2019 | Ethiopia | cross-sectional | 129 (63/66) | 286 (159/127) | 34.56±12.6 | PHQ-9 | High quality (15) |
| Wang et al., 2018 | China | cross-sectional | 222 (136/86) | 1030 | 44.35 | PHQ-9 | High quality (16) |
| Ugarte-Gil et al., 2013 | Peru | cohort study | 109 (52/57) | 182 (108/74) | CES-D | High quality (8) | |
| Walker et al., 2018 | Pakistan | cross-sectional | 547 (232/315) | 732 (427/305) | 31 (22-41) | PHQ-9 | High quality (14) |
| Zainuddin et al., 2020 | Indonesia | cross-sectional | 29 (16/13) | 63 (42/21) | BDI-II | Low quality (12) | |
| Walker et al., 2019 | Nepal | cross-sectional | 30 (20/10) | 105 (82/23) | 30 (23-43) | HSCL-25 | High quality (16) |
| Stoichita et al., 2021 | Romania | cohort study | 21 (11/10) | 25 (18/7) | 46±13.3 | HADS | Low quality (13) |
| Oh et al., 2017 | Korean | cohort study | 101 (46/55) | 191 (71/120) | 45.8±18.4 | ICD-10 | High quality (8) |
| Salodia et al., 2021 | India | cross-sectional | 25 (13/12) | 81 (48/33) | 30 (24-40) | PHQ-9 | High quality (7) |
| Paradesi et al., 2020 | India | cross-sectional | 68 (23/45) | 52 (16/36) | ICD-10 | High quality (16) | |
| Ige et al., 2011 | Nigeria | cohort study | 40 (14/26) | 48 (14/34) | 27.09±14.29 | HAM-D | High quality (6) |
| Singh et al., 2018 | India | cross-sectional | 124 (91/33) | 6 (2/4) | 29.45±14.49 | HAM-D | High quality (14) |
| Kuching et al., 2020 | Malaysia | cross-sectional | 18 | 217 | 43.7±16.6 | PHQ-9 | High quality (14) |
| Yohannes et al., 2020 | Ethiopia | cross-sectional | 186 | 223 | 31.9±11.85 | PHQ-9 | High quality (14) |
| Gong et al., 2018 | China | cross-sectional | 644 (404/240) | 698 (501/197) | 47.7±17.1 | CES-D | High quality (14) |
| Dong et al., 2020 | China | cross-sectional | 590 (349/241) | 507 (345/162) | 46.21±16.46 | CES-D | High quality (18) |
| Shrestha et al.,2020 | Nepal | cross-sectional | 81 (56/25) | 48 (36/12) | 36.78±15.62 | PHQ-9 | High quality (18) |
Figure 2Meta-analysis of risk factor gender.
Figure 3Meta-analysis of risk factor social support.
Figure 4Meta-analysis of risk factor education.
Figure 5Meta-analysis of risk factor marriage status.
Figure 6Meta-analysis of risk factor BMI.
Figure 7Meta-analysis of risk factor case status.
Figure 8Meta-analysis of risk factor residence.
Figure 9Meta-analysis of risk factor treatment phase.
Figure 10Meta-analysis of risk factor perceived stigma.
The Results of Risk Factors and Subgroups
| Risk Factor (Referrence) | Subgroup Categories | Subgroups | No. of Samples | OR (95% CI) | P value | Heterogeneity (I2), % |
|---|---|---|---|---|---|---|
| 22 | 1.319 (1.132–1.536) | 0.000 | 61.2 | |||
| Depression measurement | PHQ-9 | 9 | 1.370 (1.070–1.760) | 0.013 | 75.2 | |
| Mini-Plus | 1 | 1.510 (0.442–5.407) | 0.527 | NA | ||
| HADS | 3 | 1.370 (0.830–2.270) | 0.549 | 0.0 | ||
| CES-D | 3 | 1.504 (1.283–1.763) | 0.000 | 0.0 | ||
| BDI-II | 1 | 1.625 (0.661–3.996) | 0.290 | NA | ||
| HSCL-25 | 1 | 2.000 (0.707–5.657) | 0.191 | NA | ||
| ICD-10 | 2 | 0.819 (0.529–1.268) | 0.371 | 7.7 | ||
| HAM-D | 2 | 0.378 (0.164–0.870) | 0.022 | 0.0 | ||
| Study type | Cross-sectional | 17 | 1.378 (1.172,-1.619) | 0.000 | 62.6 | |
| Cohort | 5 | 1.067 (0.616–1.850) | 0.816 | 60.6 | ||
| Regression model type | AOR | 5 | 1.227 (1.183–1.272) | 0.000 | 0.0 | |
| COR | 17 | 1.369 (1.105–1.697) | 0.004 | 59.6 | ||
| Continent | Africa | 5 | 1.463 (0.970–2.207) | 0.070 | 74.7 | |
| Oceania | 2 | 1.044 (0.662–1.646) | 0.853 | 0.0 | ||
| Asia | 13 | 1.232 (0.980–1.548) | 0.074 | 59.4 | ||
| South America | 1 | 1.600 (0.992–2.581) | 0.054 | NA | ||
| Europe | 1 | 2.300 (0.685–7.272) | 0.179 | NA | ||
| 5 | 4.109 (1.431–11.799) | 0.009 | 96.2 | |||
| Depression | HADS | 2 | 11.023 (3.998–30.471) | 0.000 | 86.9 | |
| PHQ-9 | 3 | 2.120 (1.115–4.031) | 0.022 | 83.1 | ||
| Regression model type | COR | 4 | 2.773 (1.358–5.661) | 0.005 | 88.4 | |
| AOR | 1 | 18.060 (11.986–27.212) | 0.000 | NA | ||
| 9 | 1.921 (1.475–2.503) | 0.000 | 61.2 | |||
| Depression measurement | PHQ-9 | 4 | 1.758 (1.283–2.408) | 0.000 | 60.3 | |
| HAD | 4 | 2.473 (1.599–3.826) | 0.000 | 48.8 | ||
| ICD | 1 | 1.028 (0.464–2.777) | 0.946 | NA | ||
| Continent | Africa | 4 | 2.163 (1.425–3.284) | 0.000 | 77.9 | |
| Oceania | 2 | 1.445 (0.745–2.842) | 0.286 | 0.0 | ||
| Europe | 1 | 4.000 (1.197–16.171) | 0.026 | NA | ||
| Asia | 2 | 1.543 (1.015–2.344) | 0.042 | 34.1 | ||
| Study type | Cross-sectional | 8 | 1.886 (1.429–2.437) | 0.000 | 63.2 | |
| Cohort | 1 | 4.000 (1.197–16.171) | 0.026 | NA | ||
| 13 | 1.362 (1.154–1.608) | 0.000 | 41.4 | |||
| Depression measurement | HADS | 1 | 1.100 (0.318–3.811) | 0.880 | NA | |
| PHQ-9 | 5 | 1.498 (1.230–1.826) | 0.000 | 20.8 | ||
| MINI-Plus | 1 | 1.292 (0.477–3.499) | 0.614 | NA | ||
| BDI-II | 1 | 0.494 (0.186–1.314) | 0.158 | NA | ||
| ICD-10 | 1 | 1.744 (0.785–3.874) | 0.172 | NA | ||
| HSCL-25 | 1 | 0.707 (0.252–1.984) | 0.510 | NA | ||
| HAM-D | 2 | 0.449 (0.201–1.002) | 0.051 | 0.0 | ||
| CES-D | 1 | 1.649 (1.004–2.709) | 0.048 | NA | ||
| Continent | Europe | 1 | 1.100 (0.318–3.811) | 0.880 | NA | |
| Asia | 6 | 0.748 (0.498–1.123) | 0.161 | 28.8 | ||
| Africa | 4 | 1.566 (1.277–1.920) | 0.000 | 0.0 | ||
| Oceania | 1 | 1.090 (0.490–2.422) | 0.832 | NA | ||
| South America | 1 | 1.649 (1.004–2.709) | 0.048 | NA | ||
| Study type | Cross-sectional | 10 | 0.816 (0.458–1.453) | 0.489 | NA | |
| Cohort | 3 | 1.427 (1.200–1.696) | 0.000 | NA | ||
| 6 | 2.515 (1.226–5.159) | 0.001 | 74.5 | |||
| Regression model type | AOR | 2 | 5.152 (1.172–22.652) | 0.030 | 84.5 | |
| COR | 4 | 1.475 (1.023–2.126) | 0.037 | 0.0 | ||
| Study type | Cross-sectional | 5 | 2.956 (1.315–6.645) | 0.009 | 77.9 | |
| Cohort | 1 | 1.000 (0.306–3.266) | 1.000 | NA | ||
| Continent | Europe | 1 | 1.000 (0.306–3.266) | 1.000 | NA | |
| Asia | 2 | 2.708 (1.039–7.056) | 0.041 | 0.0 | ||
| Africa | 3 | 3.192 (1.011–10.075) | 0.048 | 88.6 | ||
| Depression measurement | HADS | 1 | 1.000 (0.306–3.266) | 1.000 | NA | |
| PHQ-9 | 4 | 3.197 (1.259–8.119) | 0.015 | 83.4 | ||
| HSCL-25 | 1 | 1.900 (0.401–9.012) | 0.419 | NA | ||
| 4 | 1.408 (1.122–1.767) | 0.010 | 0.0 | |||
| Depression measurement | 4 | 4.131 (1.412–12.088) | 0.010 | 94.9 | ||
| HADS | 2 | 10.624 (7.546–14.967) | 0.000 | 0.0 | ||
| PHQ-9 | 2 | 1.661 (1.123–2.457) | 0.011 | 25.5 |